Home > Insider Trading > Filing (0001209191-19-024269)

Filing Details

Accession Number:: 0001209191-19-024269
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2019-04-10 17:04:21
Reporting Period:: 2019-04-08

Accepted Time:: 2019-04-10 17:04:21
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1426332	Ngm Biopharmaceuticals Inc	NGM	()	4

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1347769	P L Group Column	1700 Owens Street Suite 500 San Francisco CA 94158	No	No	Yes	No
1600420	Column Group Ii, Lp	1700 Owens Street Suite 500 San Francisco CA 94158	No	No	Yes	No
1614186	Tim Kutzkey	1700 Owens Street Suite 500 San Francisco CA 94158	No	No	Yes	Yes
1614627	Column Group Gp, Lp	1700 Owens Street Suite 500 San Francisco CA 94158	No	No	Yes	No
1645333	Column Group Ii Gp, Lp	1700 Owens Street Suite 500 San Francisco CA 94158	No	No	Yes	Yes
1645340	Column Group Management Lp	1700 Owens Street Suite 500 San Francisco CA 94158	No	No	Yes	No
1707230	Ponoi Capital, Lp	1700 Owens Street Suite 500 San Francisco CA 94158	No	No	Yes	No
1720702	Ponoi Management, Llc	1700 Owens Street Suite 500 San Francisco CA 94158	No	No	Yes	Yes
1732601	Ponoi Capital Ii, Lp	1700 Owens Street Suite 500 San Francisco CA 94158	No	No	Yes	No
1746488	Ponoi Ii Management, Llc	1700 Owens Street Suite 500 San Francisco CA 94158	No	No	Yes	Yes

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2019-04-08	13,093,134	$0.00	13,569,091	No	4	C	Direct
Common Stock	Acquisiton	2019-04-08	1,875,000	$16.00	1,875,000	No	4	P	Direct
Common Stock	Acquisiton	2019-04-08	15,000	$16.00	15,000	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	C	Direct
No	4	P	Direct
No	4	P	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series A Preferred Stock	Disposition	2019-04-08	12,000,000	$0.00	6,000,000	$0.00
Common Stock	Series B Preferred Stock	Disposition	2019-04-08	8,408,933	$0.00	4,204,467	$0.00
Common Stock	Series C Preferred Stock	Disposition	2019-04-08	2,377,334	$0.00	1,188,667	$0.00
Common Stock	Series D Preferred Stock	Disposition	2019-04-08	3,400,000	$0.00	1,700,000	$0.00

Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
No	4	C	Direct
No	4	C	Direct
No	4	C	Direct
No	4	C	Direct

Footnotes

Every two shares of Series A preferred stock, Series B preferred stock, Series C preferred stock and Series D preferred stock automatically converted into one share of common stock in connection with the closing of the issuer's initial public offering, without payment of consideration. These shares have no expiration date.
Consists of 11,103,333 shares of Common Stock held directly by The Column Group, LP ("TCG LP"), 2,265,758 shares of Common Stock held directly by The Column Group II, LP ("TCG II LP"), 100,000 shares of Common Stock held directly by The Column Group GP, LP ("TCG GP") and 100,000 shares of Common Stock held directly by The Column Group Management, LP ("TCGM LP").
The securities are directly held by TCG LP, and indirectly held by TCG GP, the general partner of TCG LP. The managing partners of TCG GP are David Goeddel and Peter Svennilson. The managing partners of TCG GP may be deemed to have voting and investment power with respect to such shares. Each individual managing partner disclaims beneficial ownership of these shares, except to the extent of his pecuniary interest in such shares.
The securities are directly held by TCG II LP, and indirectly held by The Column Group II GP, LP ("TCG II GP"), the general partner of TCG II LP. The managing partners of TCG II GP are David Goeddel and Peter Svennilson. The managing partners of TCG II GP may be deemed to have voting and investment power with respect to such shares. Each individual managing partner disclaims beneficial ownership of these shares, except to the extent of his pecuniary interest in such shares.
The securities are directly held by TCG GP. The managing partners of TCG GP are David Goeddel and Peter Svennilson. The managing partners of TCG GP may be deemed to have voting and investment power with respect to such shares. Each individual managing partner disclaims beneficial ownership of these shares, except to the extent of his pecuniary interest in such shares.
The securities are directly held by TCGM LP. The managing partners of TCGM LP are David Goeddel and Peter Svennilson. The managing partners of TCGM LP may be deemed to have voting and investment power with respect to such shares. Each individual managing partner disclaims beneficial ownership of these shares, except to the extent of his pecuniary interest in such shares.
Consists of 937,500 shares of Common Stock held directly by Ponoi Capital, LP ("Ponoi LP") and 937,500 shares of Common Stock held directly by Ponoi Capital II, LP ("Ponoi II LP").
The securities are directly held by Ponoi LP, and indirectly held by Ponoi Management, LLC ("Ponoi LLC"), the general partner of Ponoi LP. The managing partners of Ponoi LLC are David Goeddel, Peter Svennilson and Tim Kutzkey. The managing partners of Ponoi LLC may be deemed to have voting and investment power with respect to such shares. Each individual managing partner disclaims beneficial ownership of these shares, except to the extent of his pecuniary interest in such shares.
The securities are directly held by Ponoi II LP, and indirectly held by Ponoi II Management, LLC ("Ponoi II LLC"), the general partner of Ponoi II LP. The managing partners of Ponoi II LLC are David Goeddel, Peter Svennilson and Tim Kutzkey. The managing partners of Ponoi II LLC may be deemed to have voting and investment power with respect to such shares. Each individual managing partner disclaims beneficial ownership of these shares, except to the extent of his pecuniary interest in such shares.
These securities are owned solely by Tim Kutzkey.
Consists of 7,200,000 shares of Series B Preferred Stock that were convertible into 3,600,000 shares of Common Stock held directly by TCG LP and 1,208,933 shares of Series B Preferred Stock that were convertible into 604,467 shares of Common Stock held directly by TCG II LP.
Consists of 2,340,000 shares of Series C Preferred Stock that were convertible into 1,170,000 shares of Common Stock held directly by TCG LP and 37,334 shares of Series C Preferred Stock that were convertible into 18,667 shares of Common Stock held directly by TCG II LP.
Consists of 666,666 shares of Series D Preferred Stock that were convertible into 333,333 shares of Common Stock held directly by TCG LP and 2,733,334 shares of Series D Preferred Stock that were convertible into 1,366,667 shares of Common Stock held directly by TCG II LP.